Financial Gravity Asset Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-8
| Closed | -$160 | – | 1968 |
|
|
2023
Q4 | $160 | Buy |
8
+4
| +100% | +$80 | ﹤0.01% | 1234 |
|
|
2023
Q3 | $73 | Buy |
+4
| New | +$73 | ﹤0.01% | 1025 |
|
|
2023
Q2 | – | Sell |
-29
| Closed | -$2.07K | – | 1637 |
|
|
2023
Q1 | $2.07K | Sell |
29
-1
| -3% | -$71 | 0.06% | 301 |
|
|
2022
Q4 | $794 | Sell |
30
-42
| -58% | -$1.11K | ﹤0.01% | 709 |
|
|
2022
Q3 | $92 | Buy |
72
+6
| +9% | +$8 | ﹤0.01% | 640 |
|
|
2022
Q2 | $87 | Sell |
66
-9
| -12% | -$12 | ﹤0.01% | 595 |
|
|
2022
Q1 | $97 | Sell |
75
-33
| -31% | -$43 | ﹤0.01% | 622 |
|
|
2021
Q4 | $138 | Buy |
108
+104
| +2,600% | +$133 | ﹤0.01% | 653 |
|
|
2021
Q3 | $43K | Hold |
4
| – | – | 0.02% | 619 |
|
|
2021
Q2 | $43K | Hold |
4
| – | – | 0.02% | 614 |
|
|
2021
Q1 | $157 | Hold |
4
| – | – | ﹤0.01% | 484 |
|
|
2020
Q4 | $0 | Buy |
+4
| New | – | ﹤0.01% | 488 |
|
|
2020
Q2 | – | Sell |
-50
| Closed | -$1.46K | – | 63 |
|
|
2020
Q1 | $1.46K | Sell |
50
-346
| -87% | -$10.1K | ﹤0.01% | 428 |
|
|
2019
Q4 | $52K | Sell |
396
-7
| -2% | -$919 | 0.04% | 615 |
|
|
2019
Q3 | $22K | Buy |
403
+77
| +24% | +$4.2K | 0.02% | 434 |
|
|
2019
Q2 | $13K | Buy |
326
+207
| +174% | +$8.26K | 0.01% | 535 |
|
|
2019
Q1 | $4K | Buy |
+119
| New | +$4K | ﹤0.01% | 722 |
|
|
2018
Q3 | $4K | Buy |
123
+15
| +14% | +$488 | ﹤0.01% | 754 |
|
|
2018
Q2 | $4K | Buy |
108
+38
| +54% | +$1.41K | ﹤0.01% | 801 |
|
|
2018
Q1 | $3K | Buy |
+70
| New | +$3K | ﹤0.01% | 824 |
|